You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Anti-malarial Medicines Market By Key Players (Novartis, F. Hoffmann-La Roche, Sun Pharmaceutical Industries, Pfizer) Based on 2020 COVID-19 Worldwide Spread

The report on the Global Anti-malarial Medicines Market has published by Lexis Business Insights. The report provides the client the latest trending insights about the Anti-malarial Medicines market. You will find in the report include market value and growth rate, size, production consumption and gross margin, pricings, and other influential factors. Along with these you will get detailed information about all the distributors, suppliers and retailers of the Anti-malarial Medicines market in the report. The competitive scenario of all the industry players are mentioned in-detail in the report. Due to the pandemic the market players have strategically changed their business plans.
Some of the key industry players that are operating in the Anti-malarial Medicines market are:
Pfizer

GlaxoSmithKline

Sun Pharmaceutical Industries

Novartis

F. Hoffmann-La Roche

Through the month of the analysis, research analysts predicted that the Anti-malarial Medicines market reached XX million dollars in 2019 and the market demand will reach XX million dollars by 2026. During the forecast period 2020 to 2026 the expected CAGR is XX%. The increasing investments in the research and development activities and the rising technological advancements in the Anti-malarial Medicines market, increasing the market growth.
Due to the increase of pandemic world-wide several market issues has generated around the world. Such as, economic crisis in various regions along with loss of employment.
The questions that are answered in the report:
What are the challenges for the Anti-malarial Medicines market created by the outbreak of the global pandemic?

What are the drivers that are shaping the Anti-malarial Medicines market?

What are the top opportunities that are currently ruling the market?

What are the segments of the Anti-malarial Medicines market that are given in the report?

What are the developing regions in the Anti-malarial Medicines market?

Overall industries are struggling on the global platform to revive the markets. It has been observed that through the pandemic almost every market domain has been impacted.
Market Segmentation
The Anti-malarial Medicines market regional presence is showcased in five major regions Europe, North America, Latin America, Asia Pacific, and the Middle East and Africa. In the report, the country-level analysis is also provided.
The Anti-malarial Medicines market is segmented into Product Types:
Atovaquone Plus Proguanil

Doxycycline

Mefloquine

Chloroquine and Proguanil

Others

The Anti-malarial Medicines market is segmented into By End User/Application:
Government/Public Sector

Charity

Private

Others

The major points that are covered in the report:
Overview:
In this section, the global Anti-malarial Medicines Market definition is given, with an overview of the report in order to provide a board outlook about the nature and contents of the research study.
Strategies Analysis of Industry Players:
This Strategic Analysis will help to gain competitive advantage over their competitors to the market players.
Essential Market Trends:
Depth analysis of the market’s latest and future trends is provided in this section.
Market Forecasts:
In this segment, accurate and validated values of the total market size in terms of value and volume have provided by the research analyst. Also the report include production, consumption, sales, and other forecasts for the global Anti-malarial Medicines Market.
Regional Analysis:
In the global Anti-malarial Medicines market report major five regions and its countries have been covered. Market players will have estimates about the untapped regional markets and other benefits with the help of this analysis.
Segment Analysis:
Accurate and reliable foretell about the market share of the essential sections of the Anti-malarial Medicines market is provided.
Regional Segmentation
North America

Latin America

Europe

Asia Pacific

Middle East and Africa

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Anti-malarial Medicines Market Share by Type (2020-2026)
1.5.2 Atovaquone Plus Proguanil
1.5.3 Doxycycline
1.5.4 Mefloquine
1.5.5 Chloroquine and Proguanil
1.5.6 Others
1.6 Market by Application
1.6.1 Global Anti-malarial Medicines Market Share by Application (2020-2026)
1.6.2 Government/Public Sector
1.6.3 Charity
1.6.4 Private
1.6.5 Others
1.7 Anti-malarial Medicines Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Anti-malarial Medicines Industry Development

2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19

3 Value Chain of Anti-malarial Medicines Market
3.1 Value Chain Status
3.2 Anti-malarial Medicines Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Anti-malarial Medicines
3.2.3 Labor Cost of Anti-malarial Medicines
3.2.3.1 Labor Cost of Anti-malarial Medicines Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19

4 Players Profiles
4.1 Pfizer
4.1.1 Pfizer Basic Information
4.1.2 Anti-malarial Medicines Product Profiles, Application and Specification
4.1.3 Pfizer Anti-malarial Medicines Market Performance (2015-2020)
4.1.4 Pfizer Business Overview
4.2 GlaxoSmithKline
4.2.1 GlaxoSmithKline Basic Information
4.2.2 Anti-malarial Medicines Product Profiles, Application and Specification
4.2.3 GlaxoSmithKline Anti-malarial Medicines Market Performance (2015-2020)
4.2.4 GlaxoSmithKline Business Overview
4.3 Sun Pharmaceutical Industries
4.3.1 Sun Pharmaceutical Industries Basic Information
4.3.2 Anti-malarial Medicines Product Profiles, Application and Specification
4.3.3 Sun Pharmaceutical Industries Anti-malarial Medicines Market Performance (2015-2020)
4.3.4 Sun Pharmaceutical Industries Business Overview
4.4 Novartis
4.4.1 Novartis Basic Information
4.4.2 Anti-malarial Medicines Product Profiles, Application and Specification
4.4.3 Novartis Anti-malarial Medicines Market Performance (2015-2020)
4.4.4 Novartis Business Overview
4.5 F. Hoffmann-La Roche
4.5.1 F. Hoffmann-La Roche Basic Information
4.5.2 Anti-malarial Medicines Product Profiles, Application and Specification
4.5.3 F. Hoffmann-La Roche Anti-malarial Medicines Market Performance (2015-2020)
4.5.4 F. Hoffmann-La Roche Business Overview

5 Global Anti-malarial Medicines Market Analysis by Regions
5.1 Global Anti-malarial Medicines Sales, Revenue and Market Share by Regions
5.1.1 Global Anti-malarial Medicines Sales by Regions (2015-2020)
5.1.2 Global Anti-malarial Medicines Revenue by Regions (2015-2020)
5.2 North America Anti-malarial Medicines Sales and Growth Rate (2015-2020)
5.3 Europe Anti-malarial Medicines Sales and Growth Rate (2015-2020)
5.4 Asia-Pacific Anti-malarial Medicines Sales and Growth Rate (2015-2020)
5.5 Middle East and Africa Anti-malarial Medicines Sales and Growth Rate (2015-2020)
5.6 South America Anti-malarial Medicines Sales and Growth Rate (2015-2020)

6 North America Anti-malarial Medicines Market Analysis by Countries
6.1 North America Anti-malarial Medicines Sales, Revenue and Market Share by Countries
6.1.1 North America Anti-malarial Medicines Sales by Countries (2015-2020)
6.1.2 North America Anti-malarial Medicines Revenue by Countries (2015-2020)
6.1.3 North America Anti-malarial Medicines Market Under COVID-19
6.2 United States Anti-malarial Medicines Sales and Growth Rate (2015-2020)
6.2.1 United States Anti-malarial Medicines Market Under COVID-19
6.3 Canada Anti-malarial Medicines Sales and Growth Rate (2015-2020)
6.4 Mexico Anti-malarial Medicines Sales and Growth Rate (2015-2020)

7 Europe Anti-malarial Medicines Market Analysis by Countries
7.1 Europe Anti-malarial Medicines Sales, Revenue and Market Share by Countries
7.1.1 Europe Anti-malarial Medicines Sales by Countries (2015-2020)
7.1.2 Europe Anti-malarial Medicines Revenue by Countries (2015-2020)
7.1.3 Europe Anti-malarial Medicines Market Under COVID-19
7.2 Germany Anti-malarial Medicines Sales and Growth Rate (2015-2020)
7.2.1 Germany Anti-malarial Medicines Market Under COVID-19
7.3 UK Anti-malarial Medicines Sales and Growth Rate (2015-2020)
7.3.1 UK Anti-malarial Medicines Market Under COVID-19
7.4 France Anti-malarial Medicines Sales and Growth Rate (2015-2020)
7.4.1 France Anti-malarial Medicines Market Under COVID-19
7.5 Italy Anti-malarial Medicines Sales and Growth Rate (2015-2020)
7.5.1 Italy Anti-malarial Medicines Market Under COVID-19
7.6 Spain Anti-malarial Medicines Sales and Growth Rate (2015-2020)
7.6.1 Spain Anti-malarial Medicines Market Under COVID-19
7.7 Russia Anti-malarial Medicines Sales and Growth Rate (2015-2020)
7.7.1 Russia Anti-malarial Medicines Market Under COVID-19

8 Asia-Pacific Anti-malarial Medicines Market Analysis by Countries
8.1 Asia-Pacific Anti-malarial Medicines Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Anti-malarial Medicines Sales by Countries (2015-2020)
8.1.2 Asia-Pacific Anti-malarial Medicines Revenue by Countries (2015-2020)
8.1.3 Asia-Pacific Anti-malarial Medicines Market Under COVID-19
8.2 China Anti-malarial Medicines Sales and Growth Rate (2015-2020)
8.2.1 China Anti-malarial Medicines Market Under COVID-19
8.3 Japan Anti-malarial Medicines Sales and Growth Rate (2015-2020)
8.3.1 Japan Anti-malarial Medicines Market Under COVID-19
8.4 South Korea Anti-malarial Medicines Sales and Growth Rate (2015-2020)
8.4.1 South Korea Anti-malarial Medicines Market Under COVID-19
8.5 Australia Anti-malarial Medicines Sales and Growth Rate (2015-2020)
8.6 India Anti-malarial Medicines Sales and Growth Rate (2015-2020)
8.6.1 India Anti-malarial Medicines Market Under COVID-19
8.7 Southeast Asia Anti-malarial Medicines Sales and Growth Rate (2015-2020)
8.7.1 Southeast Asia Anti-malarial Medicines Market Under COVID-19

9 Middle East and Africa Anti-malarial Medicines Market Analysis by Countries
9.1 Middle East and Africa Anti-malarial Medicines Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Anti-malarial Medicines Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Anti-malarial Medicines Revenue by Countries (2015-2020)
9.1.3 Middle East and Africa Anti-malarial Medicines Market Under COVID-19
9.2 Saudi Arabia Anti-malarial Medicines Sales and Growth Rate (2015-2020)
9.3 UAE Anti-malarial Medicines Sales and Growth Rate (2015-2020)
9.4 Egypt Anti-malarial Medicines Sales and Growth Rate (2015-2020)
9.5 Nigeria Anti-malarial Medicines Sales and Growth Rate (2015-2020)
9.6 South Africa Anti-malarial Medicines Sales and Growth Rate (2015-2020)

10 South America Anti-malarial Medicines Market Analysis by Countries
10.1 South America Anti-malarial Medicines Sales, Revenue and Market Share by Countries
10.1.1 South America Anti-malarial Medicines Sales by Countries (2015-2020)
10.1.2 South America Anti-malarial Medicines Revenue by Countries (2015-2020)
10.1.3 South America Anti-malarial Medicines Market Under COVID-19
10.2 Brazil Anti-malarial Medicines Sales and Growth Rate (2015-2020)
10.2.1 Brazil Anti-malarial Medicines Market Under COVID-19
10.3 Argentina Anti-malarial Medicines Sales and Growth Rate (2015-2020)
10.4 Columbia Anti-malarial Medicines Sales and Growth Rate (2015-2020)
10.5 Chile Anti-malarial Medicines Sales and Growth Rate (2015-2020)

11 Global Anti-malarial Medicines Market Segment by Types
11.1 Global Anti-malarial Medicines Sales, Revenue and Market Share by Types (2015-2020)
11.1.1 Global Anti-malarial Medicines Sales and Market Share by Types (2015-2020)
11.1.2 Global Anti-malarial Medicines Revenue and Market Share by Types (2015-2020)
11.2 Atovaquone Plus Proguanil Sales and Price (2015-2020)
11.3 Doxycycline Sales and Price (2015-2020)
11.4 Mefloquine Sales and Price (2015-2020)
11.5 Chloroquine and Proguanil Sales and Price (2015-2020)
11.6 Others Sales and Price (2015-2020)

12 Global Anti-malarial Medicines Market Segment by Applications
12.1 Global Anti-malarial Medicines Sales, Revenue and Market Share by Applications (2015-2020)
12.1.1 Global Anti-malarial Medicines Sales and Market Share by Applications (2015-2020)
12.1.2 Global Anti-malarial Medicines Revenue and Market Share by Applications (2015-2020)
12.2 Government/Public Sector Sales, Revenue and Growth Rate (2015-2020)
12.3 Charity Sales, Revenue and Growth Rate (2015-2020)
12.4 Private Sales, Revenue and Growth Rate (2015-2020)
12.5 Others Sales, Revenue and Growth Rate (2015-2020)

13 Anti-malarial Medicines Market Forecast by Regions (2020-2026)
13.1 Global Anti-malarial Medicines Sales, Revenue and Growth Rate (2020-2026)
13.2 Anti-malarial Medicines Market Forecast by Regions (2020-2026)
13.2.1 North America Anti-malarial Medicines Market Forecast (2020-2026)
13.2.2 Europe Anti-malarial Medicines Market Forecast (2020-2026)
13.2.3 Asia-Pacific Anti-malarial Medicines Market Forecast (2020-2026)
13.2.4 Middle East and Africa Anti-malarial Medicines Market Forecast (2020-2026)
13.2.5 South America Anti-malarial Medicines Market Forecast (2020-2026)
13.3 Anti-malarial Medicines Market Forecast by Types (2020-2026)
13.4 Anti-malarial Medicines Market Forecast by Applications (2020-2026)
13.5 Anti-malarial Medicines Market Forecast Under COVID-19

14 Appendix
14.1 Methodology
14.2 Research Data Source
  • FORMAT: PDF
  • PUBLISHED DATE: Jun, 2021
  • NO OF PAGES: 140